NCT02287428 |
|
Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBM
|
View
|
NCT00342589 |
|
New Techniques for Using a Saline Wash as a Diagnostic Tool for Pneumocystis Pneumonia
|
View
|
NCT00525031 |
|
Temozolomide Alone or With Pegylated Interferon-Alpha 2b PGI in Melanoma Patients
|
View
|
NCT00686387 |
|
Establishment of a Brain and Spinal Tumor Tissue Bank
|
View
|
NCT00944801 |
|
Pegylated Liposomal Doxorubicine and Prolonged Temozolomide in Addition to Radiotherapy in Newly Diagnosed Glioblastoma
|
View
|
NCT01149109 |
|
Efficacy and Safety Study of LomustineTemozolomide Combination Therapy vs Standard Therapy for Glioblastoma Patients
|
View
|
NCT01502241 |
|
Phase III Trial of Primary Radio- or Chemotherapy in Malignant Astrocytoma of the Elderly
|
View
|
NCT01656876 |
|
The Effects of Mirror Therapy on Upper Extremity in Stroke Patients
|
View
|
NCT01956734 |
|
Virus DNX2401 and Temozolomide in Recurrent Glioblastoma
|
View
|
NCT02414009 |
|
Study to Compare CAPTEM vs FOLFIRI as Second Line Treatment in Advanced Colorectal Cancer Patients
|
View
|
NCT02864368 |
|
Peptide Targets for Glioblastoma Against Novel Cytomegalovirus Antigens
|
View
|
NCT00003567 |
|
Gene Therapy and Chemotherapy in Treating Patients With Advanced Solid Tumors or Non-Hodgkins Lymphoma
|
View
|
NCT03463733 |
|
Hydroxy-urea and Temozolomide in Patients With a Recurrent Malignant Brain Tumor Glioblastoma
|
View
|
NCT03535350 |
|
Ibrutinib With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma
|
View
|
NCT03726515 |
|
CART-EGFRvIII Pembrolizumab in GBM
|
View
|
NCT01044225 |
|
Effect of Radiation Therapy Plus Temozolomide Combined With Cilengitide or Cetuximab on the 1-year Overall Survival of Patients With Newly Diagnosed MGMT-promoter Unmethylated Glioblastoma
|
View
|
NCT04689347 |
|
5FULV Irinotecan Temozolomide and Bevacizumab for MGMT Silenced Microsatellite Stable Metastatic Colorectal Cancer
|
View
|
NCT04765514 |
|
Chemoradiotherapy Versus Biomarker-Guided Therapy for Elderly and Frail GBM Patients
|
View
|
NCT04801147 |
|
Immunotherapy With Autologous Tumor Lysate-Loaded Dendritic Cells In Patients With Newly Diagnosed Glioblastoma Multiforme
|
View
|
NCT05743595 |
|
Neoantigen-based Personalized DNA Vaccine With Retifanlimab PD-1 Blockade Therapy in Patients With Newly Diagnosed Unmethylated Glioblastoma
|
View
|
NCT05031975 |
|
Temozolomide and Irinotecan in Patients With MGMT Silenced Colorectal Cancer After Adjuvant Chemotherapy
|
View
|
NCT05136326 |
|
Preoperative Chemoradiotherapy With CApecitabine and Temozolomide in MGMT Silenced MSS Locally Advanced RecTal Cancer
|
View
|
NCT05554003 |
|
Metronomic Temozolomide in Unfit NENs Patients Metronomic Temozolomide in Unfit Patients With Advanced Neuroendocrine Neoplasms NENs MeTe Study
|
View
|
NCT05653622 |
|
Simultaneous Integrated Boost FDOPA Positron Emission Tomography PET Guided in Patients With Partially- or Non-operated Glioblastoma
|
View
|
NCT03832621 |
|
NIVOLUMAB Plus IPILIMUMAB and TEMOZOLOMIDE in Microsatellite Stable MGMT Silenced Metastatic Colorectal Cancer
|
View
|
NCT04002804 |
|
Immunotherapy With Autologous Tumor Lysate-Loaded Dendritic Cells In Patients With Recurrence Of Glioblastoma Multiforme
|
View
|
NCT00365222 |
|
Phase II Study of Temozolomide in Newly Diagnosed Glioblastoma
|
View
|
NCT01308632 |
|
Metronomic Temozolamide in Patients With Recurrent Glioblastoma
|
View
|
NCT00509821 |
|
Enzastaurin Before and Concomitant With Radiation Followed by Enzastaurin in Participants With Newly Diagnosed Glioblastoma
|
View
|
NCT04396860 |
|
Testing the Use of the Immunotherapy Drugs Ipilimumab and Nivolumab Plus Radiation Therapy Compared to the Usual Treatment Temozolomide and Radiation Therapy for Newly Diagnosed MGMT Unmethylated Glioblastoma
|
View
|
NCT04421378 |
|
A Study of Selinexor in Combination With Standard of Care Therapy for Newly Diagnosed or Recurrent Glioblastoma
|
View
|
NCT00423150 |
|
Phase 2 Study of Temozolomide in Pre-Selected Advanced Aerodigestive Tract Cancers Study P04273AM2TERMINATED
|
View
|
NCT00424554 |
|
Low-dose Temozolomide for 2 Weeks on Brain Tumor Enzyme in Patients With Gliomas P04602 AM1 Completed
|
View
|
NCT00687323 |
|
Study of Temozolomide in Previously Untreated Acute Myeloid Leukemia AML and Myelodysplastic Syndrome MDS Participants With Low O6-Methylguanine Methyltransferase MGMT Expression P05052
|
View
|
NCT04614909 |
|
Study of Pamiparib in Newly Diagnosed and rGBM
|
View
|
NCT00967330 |
|
A Study of Avastin Bevacizumab and Irinotecan Versus Temozolomide Radiochemistry in Patients With Glioblastoma
|
View
|
NCT01019434 |
|
Radiation Therapy and Temsirolimus or Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma
|
View
|
NCT01700569 |
|
Phase-1 Study of Folinic Acid to Modulate MGMT Gene in Glioblastoma
|
View
|
NCT04715620 |
|
Niraparib Combined With Radiotherapy in rGBM
|
View
|
NCT01175278 |
|
Vertebral Augmentation With Kyphoplasty vs Nonsurgical Mgmt for Vertebral Body Compression Fractures
|
View
|
NCT01737346 |
|
Procarbazine and Lomustine in Recurrent Glioblastoma
|
View
|
NCT04741984 |
|
Monocyte Antigen Carrier Cells for Newly Diagnosed GBM
|
View
|
NCT01269424 |
|
BG TMZ Therapy of Glioblastoma Multiforme
|
View
|
NCT01345370 |
|
Comparison of Different Methods to Test MGMT Status in Glioblastoma Patients
|
View
|
NCT01781403 |
|
Preoperative CRT With Temozolomide Plus Capecitabine in Rectal Cancer
|
View
|
NCT02477813 |
|
Temozolomide in Patients Affected by Relapsed Sensitive or Refractory Small Cell Lung Cancer With MGMT Methylation
|
View
|
NCT01534845 |
|
Efficacy Study of Radiotherapy Alone Versus CCRT With Temozolomide in Grade III Gliomas Without 1p19q Codeletion
|
View
|
NCT04933942 |
|
Phase II Trial of Romiplostim for Thrombocytopenia Induced by Lomustine at First Progression of MGMT Promoter-meth Glioblastoma
|
View
|
NCT04967690 |
|
A Dose Escalation Study to Estimate MTD DLTs and Pharmacokinetics After a Single Intracranial Dose of SI-053 as an add-on to the Current Standard of Care in Adult Patients With Newly Diagnosed GBM
|
View
|
NCT03050736 |
|
Safety Study of VAL-083 and Radiotherapy in Patients With Newly Diagnosed GBM Having Unmethylated MGMT Expression
|
View
|
NCT05052957 |
|
hSTAR GBM Hematopoetic Stem Cell HPC Rescue for GBM
|
View
|
NCT05128734 |
|
Temozolomide Monotherapy or in Combination With Olaparib in Patients With Triple Negative Breast Cancer TNBC
|
View
|
NCT03452930 |
|
Tinostamustine With or Without Radiation Therapy in Treating Patients With Newly Diagnosed MGMT-Unmethylated Glioblastoma
|
View
|
NCT03250299 |
|
Microtubule-Targeted Agent BAL101553 and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma
|
View
|
NCT02263105 |
|
Efficacy and Tolerability of Cisplatin Plus Alternating Weekly Temozolomide in Recurrent High-grade Gliomas
|
View
|
NCT03310372 |
|
Concomitant Association of Ultrafractionated Brain Irradiation - Temozolomide in Inoperable Primary Glioblastoma Multiforme
|
View
|
NCT03665545 |
|
Pembrolizumab in Association With the IMA950Poly-ICLC for Relapsing Glioblastoma
|
View
|
NCT03519412 |
|
Pembrolizumab in MMR-Proficient Metastatic Colorectal Cancer Pharmacologically Primed to Trigger Hypermutation Status
|
View
|
NCT05685004 |
|
Study of Neoantigen-specific Adoptive T Cell Therapy for Newly Diagnosed MGMT Negative Glioblastoma Multiforme GBM
|
View
|
NCT05734560 |
|
D2C7-IT and 2141-V11 in Newly Diagnosed GBM Patients
|
View
|
NCT04215224 |
|
Histopathology Images Based Survival Prediction of Glioma Patients Using Artificial Intelligence
|
View
|
NCT03866109 |
|
A Study Evaluating Temferon in Patients With Glioblastoma Unmethylated MGMT
|
View
|
NCT02928575 |
|
Combining Sunitinib Temozolomide and Radiation to Treat Patients Diagnosed With Glioblastoma
|
View
|
NCT04555577 |
|
Peposertib and Radiation Therapy Followed by Temozolomide for the Treatment of Patients With Newly Diagnosed MGMT Unmethylated Glioblastoma or Gliosarcoma
|
View
|
NCT03011671 |
|
Study of Acetazolamide With Temozolomide in Adults With Newly Diagnosed or Recurrent Malignant Glioma
|
View
|
NCT05986851 |
|
Azeliragon in MGMT Unmethylated Glioblastoma
|
View
|
NCT03107780 |
|
Testing the Ability of AMG 232 KRT 232 to Get Into the Tumor in Patients With Brain Cancer
|
View
|
NCT03158389 |
|
NCT Neuro Master Match - N²M² NOA-20
|
View
|
NCT06095375 |
|
Regorafenib With Temozolomide With or Without RT in MGMT-Methylated IDH Wild-type GBM Patients
|
View
|
NCT03363659 |
|
Disulfiram and Copper Gluconate With Temozolomide in Unmethylated Glioblastoma Multiforme
|
View
|
NCT03367715 |
|
Nivolumab Ipilimumab and Short-course Radiotherapy in Adults With Newly Diagnosed MGMT Unmethylated Glioblastoma
|
View
|
NCT04926168 |
|
6 Months Adjuvant Temozolomide TMZ vs No Adjuvant TMZ in Newly Diagnosed MGMT Methylated Glioblastoma GBM
|
View
|
NCT03542097 |
|
Assessment of MGMT Promoter Methylation in Advanced Ewing Sarcoma Treated With Temozolomide and Irinotecan
|
View
|
NCT03743662 |
|
Nivolumab With Radiation Therapy and Bevacizumab for Recurrent MGMT Methylated Glioblastoma
|
View
|
NCT06419946 |
|
Lomustine in Addition to Standard of Care in Patients With MGMT Methylated Glioblastoma
|
View
|
NCT04166435 |
|
TMZ Olaparib for MGMT Hypermethylated Colorectal Cancer
|
View
|
NCT00560118 |
|
Fotemustine in Treating Patients With Metastatic Melanoma
|
View
|
NCT04217044 |
|
Histopathology Images Based Prediction of Molecular Pathology in Glioma Using Artificial Intelligence
|
View
|
NCT04217018 |
|
MR Based Prediction of Molecular Pathology in Glioma Using Artificial Intelligence
|
View
|
NCT04215211 |
|
MR Based Survival Prediction of Glioma Patients Using Artificial Intelligence
|
View
|
NCT04224441 |
|
Repurposing Chlorpromazine in the Treatment of Glioblastoma
|
View
|
NCT05432375 |
|
Study of Tinostamustine for Adjuvant Treatment of Glioblastoma
|
View
|
NCT05909618 |
|
Crizanlizumab Alone or in Combination With Nivolumab for Glioblastoma and Melanoma With Brain Metastases
|
View
|
NCT05806619 |
|
Glioma Biomolecular Aspects
|
View
|
NCT04573140 |
|
A Study of RNA-lipid Particle RNA-LP Vaccines for Newly Diagnosed Pediatric High-Grade Gliomas pHGG and Adult Glioblastoma GBM
|
View
|
NCT04725214 |
|
Anlotinib Combined With STUPP for MGMT Nonmethylated Glioblastoma
|
View
|
NCT05871021 |
|
Protective VEGF Inhibition for Isotoxic Dose Escalation in Glioblastoma
|
View
|
NCT04842513 |
|
Multi Peptide Vaccination With XS15 in Addition to Standard Postoperative Radiation Therapy and Temozolomide Chemotherapy in Newly Diagnosed Glioblastoma
|
View
|
NCT04893356 |
|
Impact of O6-methylguanine-DNA Methyltransferase MGMT Promoter Methylation and MGMT Expression on Dacarbazine Treated Sarcoma Patients MGMT
|
View
|
NCT04984733 |
|
Temozolomide Nivolumab in MGMT Methylated Oesophagogastric Cancer
|
View
|
NCT05033587 |
|
Study of AK105 With Anlotinib and Radiotherapy Adjuvant Therapy in MGMT Unmethylated Newly Diagnosed Glioblastoma
|
View
|
NCT06132438 |
|
Immunotherapy Targeting of Cytomegalovirus Antigens in Glioblastoma
|
View
|
NCT05095376 |
|
Testing the Addition of the Chemotherapy Drug Lomustine Gleostine to the Usual Treatment Temozolomide and Radiation Therapy for Newly Diagnosed MGMT Methylated Glioblastoma
|
View
|
NCT06538428 |
|
Methylation Patterns of the NUPR1 MGMT NDRG2 and GLI1 Genes and Their Impact on Therapeutic Outcome of GBM Patients
|
View
|
NCT06649851 |
|
G-CSF After Chemo-radiation in Patients with Glioblastoma
|
View
|
NCT06504381 |
|
DB107-RRV DB107-FC and Radiation Therapy With or Without Temozolomide TMZ for High Grade Glioma
|
View
|
NCT03548571 |
|
Dendritic Cell Immunotherapy Against Cancer Stem Cells in Glioblastoma Patients Receiving Standard Therapy
|
View
|
NCT00703859 |
|
Combining Radiotherapy and Temozolomide With Dichloroacetate in Patients With Newly Diagnosed Glioblastoma
|
View
|
NCT05629702 |
|
ARISTOCRAT Blinded Trial of Temozolomide - Cannabinoids
|
View
|
NCT05694416 |
|
Etoposide Plus Cisplatin Compared With Temozolomide in Patients With Glioblastoma
|
View
|
NCT05739942 |
|
Dose Finding Study of 177LuLu-NeoB in Newly Diagnosed Glioblastoma and in Recurrent Glioblastoma
|
View
|
NCT00977431 |
|
Open Label Trial to Explore Safety of Combining Afatinib BIBW 2992 and Radiotherapy With or Without Temozolomide in Newly Diagnosed Glioblastoma Multiform
|
View
|
NCT05938387 |
|
Safety and Tolerability of CVGBM in Adults With Newly Diagnosed MGMT-Unmethylated Glioblastoma or Astrocytoma
|
View
|
NCT01124240 |
|
Temozolomide and Procarbazine With Cilengitide for Patients With Glioblastoma Multiforme Without Methylation of the MGMT Promoter Gene
|
View
|
NCT06186440 |
|
Cisplatin Plus Temozolomide Compared With Temozolomide in Patients With MGMT Promotor Unmethylated Glioblastoma
|
View
|
NCT06282458 |
|
Dose-Finding Study Evaluating Effect on Body Composition of Enobosarm in Patients Taking a GLP-1 for Chronic Weight Mgmt
|
View
|
NCT06359379 |
|
Ropidoxuridine as a Radiosensitizer in Newly Diagnosed IDH-Wildtype Glioblastoma With Unmethylated MGMT Promoter
|
View
|
NCT06363162 |
|
Evaluate the Effectiveness and Safety of Raman IVD Analyzer in the Molecular Diagnosis of Gliomas During Surgery
|
View
|
NCT06388733 |
|
A Study Comparing Niraparib With Temozolomide in Adult Participants With Newly-diagnosed MGMT Unmethylated Glioblastoma
|
View
|
NCT00591370 |
|
Phase II Trial of Extended-Dosing Temozolomide in Patients With Melanoma
|
View
|
NCT00720356 |
|
Bevacizumab and Erlotinib After Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma
|
View
|
NCT05109728 |
|
A Dose Finding Study of 177LuLu-DOTA-TATE in Newly Diagnosed Glioblastoma in Combination With Standard of Care and in Recurrent Glioblastoma as a Single Agent
|
View
|
NCT01402063 |
|
PPX and Concurrent Radiation for Newly Diagnosed Glioblastoma Without MGMT Methylation
|
View
|
NCT02152982 |
|
Temozolomide With or Without Veliparib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
|
View
|
NCT02209948 |
|
Temozolomide 12 Cycles Versus 6 Cycles of Standard First-line Treatment in Patients With Glioblastoma
|
View
|
NCT00293280 |
|
Lomustine in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
|
View
|
NCT00265174 |
|
Serum DNA Analysis Potential Application for Diagnosis and Prognosis in Brain Cancer
|
View
|
NCT00689221 |
|
Cilengitide Temozolomide and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma and Methylated Gene Promoter Status
|
View
|
NCT00717210 |
|
Randomized Phase III Study of Sequential Radiochemotherapy of Anaplastic Glioma With PCV or Temozolomide
|
View
|
NCT00781898 |
|
Treatment Study Using Depot Naltrexone 16 Philadelphia CoordData Mgmt Site
|
View
|
NCT00813943 |
|
Cilengitide Temozolomide and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma and Unmethylated Gene Promoter Status
|
View
|
NCT00854464 |
|
Arsenic Methylation Enzymes Cigarette Metabolites DNA Repair Enzymes Inflammatory Factors and Urothelial Carcinoma
|
View
|
NCT00883298 |
|
Bi-weekly Temozolomide Plus Bevacizumab for Adult Patients With Recurrent Glioblastoma Multiforme
|
View
|
NCT02451631 |
|
The Mobile Diabetes Mgmt Study With Type 2 Diabetes
|
View
|
NCT02617589 |
|
An Investigational Immuno-therapy Study of Nivolumab Compared to Temozolomide Each Given With Radiation Therapy for Newly-diagnosed Patients With Glioblastoma GBM a Malignant Brain Cancer
|
View
|
NCT02667587 |
|
An Investigational Immuno-therapy Study of Temozolomide Plus Radiation Therapy With Nivolumab or Placebo for Newly Diagnosed Patients With Glioblastoma GBM a Malignant Brain Cancer
|
View
|
NCT02717962 |
|
Study of VAL-083 in Patients With MGMT Unmethylated Bevacizumab-naive Glioblastoma in the Adjuvant or Recurrent Setting
|
View
|
NCT02751138 |
|
Determination of Immune Phenotype in Glioblastoma Patients
|
View
|
NCT03156036 |
|
Preoperative CRT With Capecitabine Temozolomide in Patients With LARC
|
View
|
NCT03217097 |
|
MGMT-NET O6-methylguanine-DNA Methyltransferase MGMT Status in Neuroendocrine Tumors Predictive Factor of Response to Alkylating Agents
|
View
|
NCT03370926 |
|
FET-PET and Multiparametric MRI for High-grade Glioma Patients Undergoing Radiotherapy
|
View
|
NCT03522298 |
|
Safety Pharmacokinetics and Efficacy of Paxalisib GDC-0084 in Newly-diagnosed Glioblastoma
|
View
|
NCT03643549 |
|
Bortezomib and Temozolomide in Recurrent Grade-4 Glioma Unmethylated MGMT Promoter BORTEM-17
|
View
|
NCT03687034 |
|
A Study of the Safety and Pharmacokinetics of BRCX014 in Patients With Glioblastoma
|
View
|
NCT03688178 |
|
DC Migration Study to Evaluate TReg Depletion In GBM Patients With and Without Varlilumab
|
View
|
NCT03970447 |
|
A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
|
View
|
NCT04121455 |
|
Glioblastoma Treatment With Irradiation and Olaptesed Pegol NOX-A12 in MGMT Unmethylated Patients
|
View
|